GlassScriptPhysician profile
Molly Ann Bart
NPI 1700420155
$359.74
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.07 · 2023: $94.27 · 2024: $31.74 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $164.30 | 2024-2025 | Xcell, Durolane |
| Abbvie INC. | $49.65 | 2023 | |
| Lilly USA, LLC | $36.03 | 2022-2025 | Zepbound |
| Pacira Pharmaceuticals Incorporated | $18.99 | 2025 | Zilretta, Iovera |
| Depuy Synthes Sales INC. | $17.42 | 2024 | Monovisc |
| Exact Sciences Corporation | $15.85 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.53 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.49 | 2023 | Breztri |
| Merck Sharp & Dohme LLC | $14.28 | 2023 | Vaxelis, Vaqta, Gardasil 9 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Bart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.